Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Interpace Biosciences specializes in esoteric molecular diagnostic testing and pathology services for cancer risk assessment. Its core offerings include genomic tests and assays for gastrointestinal, endocrine, and lung cancers, aiding physicians in diagnosis, risk stratification, and personalized treatment decisions. Serving hospitals, clinics, and labs, the company emphasizes clinical utility, reimbursement support, and innovative research to improve patient outcomes and reduce unnecessary surgeries.
This description was generated via AI from an annual report. Updated about 1 year ago.